Healio Psoriatic Disease Current Issue
The following articles appeared in the print edition of Healio Psoriatic Disease.
Table of Contents
- Planning, options necessary in treating pregnant women with psoriasis Rebecca L. Forand
-
- New COVID-19 drug, same playbook: Like hydroxychloroquine, ivermectin lacks 'strong data' Rob Volansky
- Q&A: Rebuilding trust between physicians, patients, health care leaders Janel Miller
- Cutaneous reactions to Pfizer, Moderna COVID-19 vaccines minor Rebecca L. Forand
- Guselkumab increases enthesitis resolution rates in psoriatic arthritis Jason Laday
- Infection risk lower with ustekinumab than other biologics, apremilast in PsA, psoriasis Jason Laday
- Low birth weight not associated with topical corticosteroid use in pregnancy Rebecca L. Forand
- Plaque phenotype, IL-23 at baseline may predict downstream severe psoriasis Rob Volansky
- Bimekizumab for psoriasis demonstrates safety, efficacy in phase 3 studies Maria Marabito
-
- COVID-19 vaccine safety data 'provide reassurance' for patients with rheumatic diseases Rob Volansky
- Deucravacitinib superior to placebo, apremilast in phase 3 plaque psoriasis trials Rebecca L. Forand
- JAK inhibitors 'may prove useful' in wider range of immune-mediated inflammatory diseases Jason Laday
- Sleep 'intimately tied' to increased inflammation, worse disease course in IMIDs Jason Laday
- Tapinarof improves plaque psoriasis severity in phase 3 trials Rebecca L. Forand